AllianceBernstein
INBX icon

AllianceBernstein’s Inhibrx INBX Stock Holding History

AllianceBernstein’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$649K Buy
9,650
+700
+8% +$70.1K ﹤0.01% 2585
2026
Q1 		$707K Hold
8,950
– – ﹤0.01% 2479
2025
Q4 		$707K Sell
8,950
-10,280
-53% -$700K ﹤0.01% 2487
2025
Q3 		$648K Sell
19,230
-1,190
-6% -$29.3K ﹤0.01% 2545
2025
Q2 		$291K Buy
20,420
+2,490
+14% +$32.2K ﹤0.01% 2926
2025
Q1 		$251K Hold
17,930
– – ﹤0.01% 2850
2024
Q4 		$276K Hold
17,930
– – ﹤0.01% 2916
2024
Q3 		$281K Sell
17,930
-1,280
-7% -$18K ﹤0.01% 2944
2024
Q2 		$272K Buy
+19,210
New +$300K ﹤0.01% 2946

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AllianceBernstein's INBX Position: Q2 2026 in Review

AllianceBernstein increased its Inhibrx (INBX) stake by 7.8% in Q2 2026, buying an estimated $70.1K and bringing the position to 9,650 shares worth $649K. The position accounts for ﹤0.01% of the portfolio, ranked #2585.

AllianceBernstein first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. The position peaked at $707K in Q1 2026. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • AllianceBernstein held 9,650 shares of Inhibrx worth $649K as of Q2 2026.
  • AllianceBernstein bought 700 Inhibrx shares in Q2 2026, an estimated $70.1K.
  • Inhibrx made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2585 holding.
  • AllianceBernstein first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • AllianceBernstein's Inhibrx position peaked at $707K in Q1 2026.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.